Cytosorbents Corporation (CTSO)

Cytosorbents Revenue

In the year 2023, Cytosorbents had annual revenue of $36.35M with 4.79% growth. Revenue in the quarter ending December 31, 2023 was $8.67M, a -7.69% decrease year-over-year.

• Revenue (ttm): $36.35M
• Revenue Growth: +4.79%
• P/S Ratio: 1.20
• Revenue / Employee: $195,427
• Employees: 186
• Market Cap: 43.86M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	36.35M	1.66M	4.79%
Dec 31, 2022	34.69M	-8.48M	-19.64%
Dec 31, 2021	43.17M	2.16M	5.27%
Dec 31, 2020	41.00M	16.06M	64.35%
Dec 31, 2019	24.95M	2.45M	10.87%
Dec 31, 2018	22.50M	7.35M	48.53%
Dec 31, 2017	15.15M	5.62M	59.02%
Dec 31, 2016	9.53M	4.74M	98.84%
Dec 31, 2015	4.79M	668.79K	16.22%
Dec 31, 2014	4.12M	1.70M	70.18%
Dec 31, 2013	2.42M	1.08M	80.40%
Dec 31, 2012	1.34M	1.31M	3,622.31%
Dec 31, 2011	36.08K	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-
Dec 31, 2006	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.